Empresa Annexin Pharmaceuticals AB (publ) Nasdaq Stockholm
Acciones
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Anna Frostegård
FOU | Founder | 51 | 01/01/14 |
Chief Executive Officer | 63 | 01/01/18 | |
Director of Finance/CFO | 53 | 11/04/23 | |
Susan Suchdev
COO | Chief Operating Officer | 52 | - |
Alain Thibault
PRN | Corporate Officer/Principal | - | 18/01/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 01/01/21 |
Mårten Österlund
BRD | Director/Board Member | 67 | 01/01/21 |
Chief Executive Officer | 63 | 01/01/18 | |
Director/Board Member | 48 | 01/01/17 | |
Director/Board Member | 65 | 01/01/16 | |
Director/Board Member | 66 | 01/01/17 | |
Director/Board Member | 71 | - | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 01/01/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 526 807 199 | 75 900 956 ( 14,41 %) | 0 | 14,41 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,42 % | 115 mil M | |
+11,84 % | 106 mil M | |
-1,05 % | 21,96 mil M | |
-14,15 % | 21,84 mil M | |
-5,29 % | 19,21 mil M | |
-4,16 % | 18,08 mil M | |
-38,29 % | 17,71 mil M | |
+7,99 % | 14,32 mil M | |
+36,24 % | 12,42 mil M |